Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE.
Stepan (SCL) is back on investor radars after the company reported stronger second quarter results, announced board and executive changes, and reaffirmed its quarterly cash dividend on July 29, 2026.
See our latest analysis for Stepan.
Stepan's recent governance changes and dividend affirmation have come alongside strong momentum in the share price, with a 30-day share price return of 13.18% and a year to date gain of 35.62%, while the 1-year total shareholder return of 33.94% contrasts with weaker 3 and 5 year total shareholder returns.
If Stepan's recent move has you thinking about where else growth and income stories might emerge next, it could be worth scanning 20 top founder-led companies
Following a sharp rebound in Stepan's share price, along with a mix of stronger quarterly earnings and a six-month loss, the balance between upside potential and downside risk has become tighter. Does the current valuation still favor new buyers?
On the numbers available today, Stepan looks inexpensive on several valuation checks. The stock last closed at $63.96 and is described as trading at good value compared to peers and industry, while also sitting 60.8% below an internal fair value estimate based on future cash flows of $163.25.
The key reference point here is Stepan's P/S ratio of 0.6x. This compares to an estimated fair P/S ratio of 0.6x, a peer average of 1.2x and a US Chemicals industry average of 1.1x. The internal SWS DCF model also points to Stepan at $63.96 trading below an estimated future cash flow value of $163.25, which frames the current market price as well below that model's assessment of long term cash generation potential.
The P/S multiple matters for Stepan because the company is currently unprofitable, so earnings based ratios are less helpful. Using revenue helps investors compare what the market is paying for each dollar of Stepan's $2,432.79m in annual revenue, especially while net income is a loss of $2.65m and profit margins are not yet a clear guide.
Against that backdrop, a P/S of 0.6x that lines up with an estimated fair P/S of 0.6x sends a clear signal. The market is pricing Stepan's revenue at a discount to sector averages, yet closely in line with where the fair ratio model suggests it could settle over time. If sentiment or fundamentals shift closer to peer levels, the current discount to the 1.1x to 1.2x industry range leaves scope for the multiple to move closer to those benchmarks.
Explore the SWS fair ratio for Stepan
Result: Price-to-Sales of 0.6x (UNDERVALUED)
However, Stepan still carries risks, including recent net losses and weaker 3 and 5 year total shareholder returns that could limit the extent of any valuation re-rating.
Find out about the key risks to this Stepan narrative.
The earlier P/S work presents Stepan as inexpensive on revenue. Our DCF model points in the same direction, with an estimated future cash flow value of $163.25 per share versus the current $63.96. Both signals indicate a lower valuation relative to this estimate, which raises a simple question for investors: What if the market is slow to close that gap?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Stepan for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 50 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Given the mix of positives and concerns around Stepan, it makes sense to check the underlying data yourself and decide quickly where you stand. To weigh both sides in one place, start with the 3 key rewards and 1 important warning sign.
If Stepan has sharpened your focus on valuation, capital strength, and income, it makes sense to keep building a watchlist of other potential opportunities.
Target resilient cash generators by scanning 50 high quality undervalued stocks that combine solid fundamentals with prices that sit below internal estimates of worth.
Strengthen your income focus by reviewing 9 dividend fortresses that pair higher yields with an emphasis on resilience and consistency.
Prioritise capital protection by checking 78 resilient stocks with low risk scores designed to highlight companies with lower risk scores and sturdier profiles.
Use these ideas now so you are not looking back later wishing you had built your list of alternatives while the data was at your fingertips.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SCL.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]